Liver transplant outcomes improve over time
from MedPage Today
The advent of direct-acting anti-hepatitis C agents (DAAs) appears to have improved both patient and graft survival after liver transplant, a researcher said here. In almost all cases, patients with chronic hepatitis C (HCV) who undergo liver transplant see the virus quickly recur, with rapid progression to fibrosis and cirrhosis, according to Nyan Latt, MD, of the Mayo Clinic in Jacksonville, Fla.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063